Medicare Enrolled
Dr. Herkanwal Khaira, MD
Urology Physician · Fairfield, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khaira from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khaira?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khaira
Dr. Herkanwal Khaira is an urology physician in Fairfield, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Khaira performed 2,686 Medicare services across 1,867 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khaira received a total of $340,025 from 57 pharmaceutical and/or device companies across 415 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khaira is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 30% volume in CA
$340,025 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,686
Medicare services
Top 30% in CA for urology physician
1,867
Unique beneficiaries
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~141 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
756 | $73 | $219 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
458 | $102 | $317 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
291 | $215 | $651 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 213 | $133 | $1,541 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
144 | $31 | $40 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
100 | $134 | $472 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
83 | $56 | $187 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
78 | $12 | $42 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
76 | $82 | $314 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
66 | $7 | $33 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
62 | $79 | $252 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
43 | $31 | $98 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
41 | $21 | $228 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
28 | $72 | $238 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
27 | $119 | $1,421 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
24 | $6 | $42 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
23 | $344 | $1,102 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
23 | $30 | $201 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
21 | $192 | $512 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
21 | $56 | $78 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
20 | $332 | $1,164 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
20 | $130 | $454 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
16 | $305 | $878 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
14 | $288 | $984 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
14 | $568 | $5,199 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
13 | $230 | $810 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
11 | $164 | $2,404 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.3% high complexity
9.2% medium
88.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$340,025
Total received (2018-2024)
Avg $48,575/year across 7 years
Top 1% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
415
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$267,818 (78.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$65,833 (19.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,374 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,087
2023
$1,577
2022
$22,576
2021
$34,928
2020
$64,895
2019
$155,435
2018
$55,527
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$3,565
PROCEPT BioRobotics Corporation
$327
Janssen Biotech, Inc.
$143
Myriad Genetic Laboratories, Inc.
$131
PFIZER INC.
$128
BLUEWIND MEDICAL
$126
Astellas Pharma US Inc
$98
Merck Sharp & Dohme LLC
$72
Boston Scientific Corporation
$68
ABBVIE INC.
$51
Agiliti Surgical, Inc.
$49
Laborie Medical Technologies Corp.
$44
ACCORD HEALTHCARE, INC.
$40
Baxter Healthcare
$36
GlaxoSmithKline, LLC.
$29
Ferring Pharmaceuticals Inc.
$26
COLOPLAST CORP
$26
Olympus America Inc.
$22
Sumitomo Pharma America, Inc.
$19
Pacira Pharmaceuticals Incorporated
$19
AngioDynamics, Inc.
$18
Janssen Pharmaceuticals, Inc
$18
Medtronic, Inc.
$16
Endo USA, Inc.
$15
Top 3 companies account for 79.3% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$147,525
Ethicon Inc.
$121,730
Teleflex LLC
$56,318
Intuitive Surgical, Inc.
$6,000
Auris Health, Inc.
$1,800
PROCEPT BioRobotics Corporation
$1,142
Janssen Biotech, Inc.
$865
Astellas Pharma US Inc
$859
Myriad Genetic Laboratories, Inc.
$494
Boston Scientific Corporation
$469
Ethicon Endo-Surgery Inc.
$450
Merck Sharp & Dohme LLC
$217
PFIZER INC.
$153
Medtronic, Inc.
$143
CONMED Corporation
$142
COLOPLAST CORP
$137
BLUEWIND MEDICAL
$126
180 Medical, Inc.
$122
GlaxoSmithKline, LLC.
$122
Olympus America Inc.
$80
ABBVIE INC.
$79
Janssen Pharmaceuticals, Inc
$73
Agiliti Surgical, Inc.
$71
Dornier MedTech America, Inc
$69
PolyNovo North America LLC
$53
Rochester Medical Corporation
$48
Allergan, Inc.
$48
Actelion Pharmaceuticals US, Inc.
$46
Allergan Inc.
$46
Laborie Medical Technologies Corp.
$44
ACCORD HEALTHCARE, INC.
$40
AbbVie, Inc.
$39
Baxter Healthcare
$36
Endo Pharmaceuticals Inc.
$34
Ambu Inc.
$33
DENTSPLY IH AB
$31
Dendreon Pharmaceuticals LLC
$31
Ferring Pharmaceuticals Inc.
$26
PRESCIENT SURGICAL
$21
Sumitomo Pharma America, Inc.
$19
Pacira Pharmaceuticals Incorporated
$19
C. R. Bard, Inc. & Subsidiaries
$19
AngioDynamics, Inc.
$18
Sagent Pharmaceuticals, Inc.
$17
Heron Therapeutics, Inc.
$17
Stryker Corporation
$16
UROGEN PHARMA, INC.
$16
Endo USA, Inc.
$15
Hologic Sales and Service, LLC
$14
UROVANT SCIENCES INC
$14
C. R. BARD, INC. & SUBSIDIARIES
$13
Avadel Specialty Pharmaceuticals, LLC
$13
UroGen Pharma, Inc.
$12
BOSTON SCIENTIFIC CORPORATION
$12
DENTSPLY IH Inc.
$12
Photocure Inc
$12
Travere Therapeutics, Inc.
$3
Top 3 companies account for 95.7% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AIM (ADVANCED IMAGING MODALITY) · AIRSEAL · AMS · AQUABEAM SYSTEM · AREXVY · AVEED · Androgel · AquaBeam Robotic System · BOTOX · CAMCEVI · CURE CATHETER · CURE ULTRA CATHETER · CleanCision · CoolSeal Generator · Cysview · Da Vinci Surgical System · Dornier MedTech · ERLEADA · Erleada · Exparel · GEMTESA · GENERAL BPH · GENERAL BPH · General - Erectile Dysfunction · General - Kidney Stone Disease · Genesis · GentleCath · Glydo · Hillrom - Carnation Ambulatory Monitor · JELMYTO · KEYTRUDA · LITHOVUE · LithoVue · LoFric · Luja Coude · Lupron Depot · MAGIC3 · MYRBETRIQ · MYRISK · Monarch · Monarch Platform · Myrbetriq · NANOKNIFE · NUCALA · Noctiva · OPSUMIT · Olympus Cysto-Resection · Optilume BPH Drug Coated Balloon Catheter · PERCLOT · PROLARIS · PROVENGE · Prolaris · REVI · ROCHESTER MAGIC3 · SIGNIA · Sonablate · Sonablate HIFU · Thiola · Titan · URETERO-RENO VIDEOSCOPE · UROLIFT · UROLIFT SYSTEM · UroLift · UroLift 2 System · UroLift System · XARELTO · XIAFLEX · XTANDI · Xtandi · Zynrelef · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (79%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for urology physician in CA.
Geographic Context
Urology physicians within 10 mi
35
Per 100K population
7.8
County median income
$99,994
Nearest hospital
NORTHBAY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khaira is a clinical cardiology specialist, with above-average Medicare volume (top 30% in CA), with speaking/promotional industry engagement in the top 1% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khaira experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Khaira performed 756 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khaira receive payments from pharmaceutical companies?
Yes. Dr. Khaira received a total of $340,025 from 57 companies across 415 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khaira's costs compare to other urology physicians in Fairfield?
Dr. Khaira's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khaira) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Fairfield
Browse urology physicians in Fairfield ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Ethicon Inc. Payments to Doctors
See all physicians who received payments from Ethicon Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology